BCM
DRTX

Bridgeway Capital Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bridgeway Capital Management’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-76,150
Closed -$966K – 1572
2014
Q3 		$966K Hold
76,150
– – 0.02% 771
2014
Q2 		$1.3M Hold
76,150
– – 0.03% 671
2014
Q1 		$1.02M Hold
76,150
– – 0.03% 743
2013
Q4 		$974K Hold
76,150
– – 0.03% 754
2013
Q3 		$688K Buy
76,150
+28,650
+60% +$238K 0.02% 877
2013
Q2 		$342K Buy
+47,500
New +$349K 0.01% 1115

Bridgeway Capital Management's DRTX Position: Q4 2014 in Review

Bridgeway Capital Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 76,150 shares — an estimated $966K sold.

Bridgeway Capital Management first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $1.3M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Bridgeway Capital Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Bridgeway Capital Management sold 76,150 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $966K.
  • Bridgeway Capital Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Bridgeway Capital Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.3M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Bridgeway Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.